S. Ghosh

发表

Whole gut lavage fluid analysis : a minimally invasive method for study of mucosal immunity and inflammation.

H. Drummond, I. Arnott, A. Dahele, 2000, Methods in molecular medicine.

Assessment of Ileoanal Pouch Inflammation by Interleukin 1β and Interleukin 8 Concentrations in the Gut Lumen

S. Ghosh, D. Hamer‐Hodges, D. Bartolo, 2002, Diseases of the colon and rectum.

Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole-gut lavage fluid.

A. Ferguson, S. Ghosh, L. Handy, 1996, Scandinavian journal of gastroenterology.

How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease

S. Ghosh, M. Shale, S. Ghosh, 2009, Gut.

Anisakiasis--a neglected diagnosis in the West.

S. Ghosh, A. Akbar, S. Ghosh, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn Disease

I. Arnott, S. Ghosh, K. Kingstone, 2000, Scandinavian journal of gastroenterology.

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

P. Anand, Y. Yiangou, P. Facer, 2008, Gut.

Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence

P. Desreumaux, S. Ghosh, S. Ghosh, 2006, Alimentary pharmacology & therapeutics.

Hepcidin: what every gastroenterologist should know

D. V. van Heel, S. Ghosh, R J Playford, 2004, Gut.

Dyspepsia in primary care--to prescribe or to investigate?

S. Ghosh, M. Kinnear, S. Ghosh, 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.

K. Heaton, S. Ghosh, F. Braddon, 1991, Gut.

Trial of trefoil factor 3 enemas, in combination with oral 5‐aminosalicylic acid, for the treatment of mild‐to‐moderate left‐sided ulcerative colitis

R. Playford, S. Ghosh, A. Mahmood, 2005, Alimentary pharmacology & therapeutics.

Effects of growth factors and receptor blockade on gastrointestinal cancer

S. Ghosh, S. Ghosh, R. Playford, 2004, Gut.

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

A. Forbes, S. Schreiber, C. Probert, 2003, Gut.

Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission.

H. Drummond, I. Arnott, S. Ghosh, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis

R. Playford, J. Boyle, S. Ghosh, 2004, Peptides.

Use of the ‘nutriceutical’, bovine colostrum, for the treatment of distal colitis: results from an initial study

R. Playford, N. Wright, A. Wicks, 2002, Alimentary pharmacology & therapeutics.

The Role of Serological Tests in Redefining Coeliac Disease

S. Ghosh, A. Dahele, S. Ghosh, 2000, Journal of the Royal College of Physicians of Edinburgh.

Interfering with interferons in inflammatory bowel disease

S. Ghosh, M. Carpani, R. Chaudhary, 2005, Gut.

Incidence of juvenile-onset Crohn's disease in Scotland

H. Drummond, A. Ferguson, S. Ghosh, 1999, The Lancet.

Is thiopurine therapy in ulcerative colitis as effective as in Crohn’s disease?

S. Ghosh, M. Carpani, R. Chaudhary, 2005, Gut.

Dietary microparticles implicated in Crohn’s disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli

J. Powell, J. Boyle, M. Butler, 2007, Inflammation Research.

Cytokines and growth factor modulators in intestinal inflammation and repair

S. Ghosh, R. Playford, S. Ghosh, 2005, The Journal of pathology.

Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease

A. Forbes, C. Mathew, D. Jewell, 2005, Gut.

Dietary modulation of peroxisome proliferator-activated receptor gamma

P. Déchelotte, R. Marion-Letellier, M. Iacucci, 2008, Gut.

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

I. Arnott, S. Ghosh, D. Watts, 2002, Alimentary pharmacology & therapeutics.

Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study

H. Drummond, B. Tiplady, A. Ferguson, 1995, Quality of Life Research.

Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension.

A. Stanley, A. Ferguson, S. Ghosh, 1996, Gastroenterology.

Immunoglobulin G and albumin levels in whole gut lavage fluid provide an objective measure of pouch ileitis

D. Hamer‐Hodges, D. Bartolo, N. Evgenikos, 2000, The British journal of surgery.

Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents

S. Ghosh, A. Akbar, J. Walters, 2009, Alimentary pharmacology & therapeutics.

Management of gastrointestinal haemorrhage

S. Ghosh, S. Ghosh, S. Ghosh, 2002, Postgraduate medical journal.

Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro.

S. Ghosh, A. Shand, J. Bode, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Analysis of disease distribution, activity and complications in the patient with inflammatory bowel disease.

A. Ferguson, S. Ghosh, M. Mcintyre, 1994, Scandinavian journal of gastroenterology. Supplement.

Altered subjective appetite parameters in Crohn's disease patients.

E. Bannerman, S. Ghosh, M. Aldhous, 2001, Clinical nutrition.

Characterization of conditions for the primary culture of human small intestinal epithelial cells

S. Ghosh, A. N. Shmakov, J. Bode, 2001, Clinical and experimental immunology.

Frequency of Continuing Mucosal Inflammation in Clinically Inactive Crohn's Disease

H. Drummond, S. Ghosh, I. Arnott, 2001, Scottish medical journal.

Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis.

W. Hannan, S. Ghosh, S. Cowen, 1994, Gastroenterology.

Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes

R. Playford, S. Ghosh, T. Marchbank, 2006, Gut.

Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.

I. Arnott, S. Ghosh, Subrata Ghosh, 2000, European journal of gastroenterology & hepatology.

The spectrum of ischaemic colitis.

A. Ferguson, I. Arnott, S. Ghosh, 1999, European journal of gastroenterology & hepatology.

Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases.

S. Ghosh, M. Aldhous, A. Dahele, 2001, QJM : monthly journal of the Association of Physicians.

Prediction of response to infliximab in Crohn's disease.

S. Ghosh, R. Chaudhary, S. Ghosh, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Reparative properties of a commercial fish protein hydrolysate preparation

R. Playford, B. Ritz, S. Ghosh, 2005, Gut.

administration Gastroprotective effects of oral nucleotide

S. Ghosh, S. Ghosh, T. Marchbank, 2005 .

Modification of enteral diets in inflammatory bowel disease

S. Ghosh, M. Aldhous, D. Meister, 2001, Proceedings of the Nutrition Society.

Probiotics in inflammatory bowel disease: is it all gut flora modulation?

D. Heel, R. Playford, S. Ghosh, 2004, Gut.

Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience

S. Ghosh, I. Arnott, D. Mcdonald, 2001, Alimentary pharmacology & therapeutics.

Colonic Diseases

S. Ghosh, S. Ghosh, 2003, Humana Press.